Please submit your RFI, RFPs or questions to:
Amy Zastawney, RN, MPH
Vice President, Business Development
Tel : +1-617-697-7175
Located in Boston, Massachusetts and San Antonio, Texas, Intrinsic Imaging is an FDA audited, ISO 9001:2008 and ISO 13485:2003 certified, GAMP® 5 compliant medical imaging core lab specializing in providing imaging core lab services for clinical trials.
At Intrinsic Imaging our team of more than sixty board-certified diagnostic radiologists have sub-specialization in all therapeutic areas including, but not limited to, Cardiovascular, Central Nervous System, Gastrointestinal & Genitourinary, Musculoskeletal, Medical Device, and Oncology.
ISO 9001:2008, 13485:2003 - GAMP® 5 Imaging CRO Experienced Clinical Trial Team
Professional Radiologist Services
A Top Radiology Practice
+23 Medical Imaging Centers
+1 Million Images Annually
Our medical imaging core lab services are comprehensive and include, but are not limited to, expert radiologist consultation, protocol and charter development, site qualification, training and management, as well as image acquisition, processing and detailed radiologic analysis.
Depending on the therapeutic area, region of interest and drug candidate properties, various image modalities may be required during clinical evaluation. At Intrinsic Imaging, our broad experience and expertise in all image modalities ensures our ability to evaluate, select and train appropriate clinical trial sites as well as to provide expert interpretation of the images.
Central Nervous System
CT with expertise in multislice imaging
Digital and Conventional Radiography
Min. Invasive Image Guided Therapies
MRI, MRA, DCMRI
Nuclear Medicine : MUGA, SPECT
Ultrasound including Echocardiography
Expert Radiologist Consultation
Image Charter Development
Investigator Site Qualification
Investigator Site Training
Expert Image Analysis
Intrinsic Imaging is a member of the South Texas Radiology Group (STRG) family of companies, one of the nation's preeminent radiology practices
01/29/2015 - DOTmed Daily News - Q&A with Andrea Falkoff